Glycoprotein hormones

LH β subunit

LH β subunit

LH β subunit

LH β subunit

LH β subunit

LH β subunit

P-gp inhibitor 1 is a novel inhibitor reversing P-glycoprotein -mediated multidrug resistance.In VitroP-gp inhibitor 1 (12k) possesses high potency ( EC 50 =57.9±3.5 nM), low cytotoxicity, and long duration of activity in reversing doxorubicin (DOX)

P-gp inhibitor 1 is a novel inhibitor reversing P-glycoprotein -mediated multidrug resistance.In VitroP-gp inhibitor 1 (12k) possesses high potency ( EC 50 =57.9±3.5 nM), low cytotoxicity, and long duration of activity in reversing doxorubicin (DOX)

P-gp inhibitor 1 is a novel inhibitor reversing P-glycoprotein -mediated multidrug resistance.In VitroP-gp inhibitor 1 (12k) possesses high potency ( EC 50 =57.9±3.5 nM), low cytotoxicity, and long duration of activity in reversing doxorubicin (DOX)

P-gp inhibitor 1 is a novel inhibitor reversing P-glycoprotein -mediated multidrug resistance.In VitroP-gp inhibitor 1 (12k) possesses high potency ( EC 50 =57.9±3.5 nM), low cytotoxicity, and long duration of activity in reversing doxorubicin (DOX)

P-gp inhibitor 1 is a novel inhibitor reversing P-glycoprotein -mediated multidrug resistance.In VitroP-gp inhibitor 1 (12k) possesses high potency ( EC 50 =57.9±3.5 nM), low cytotoxicity, and long duration of activity in reversing doxorubicin (DOX)

P-gp inhibitor 1 is a novel inhibitor reversing P-glycoprotein -mediated multidrug resistance.In VitroP-gp inhibitor 1 (12k) possesses high potency ( EC 50 =57.9±3.5 nM), low cytotoxicity, and long duration of activity in reversing doxorubicin (DOX)